Arijit Chakravarty, MD
Nephrology · Morgantown, WVNPI 1386778199
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $14,381 of the $18,877 with a category attached, or 76.2%. Bayer accounts for 83.8% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $11,253 and has fallen 99.3% since, to $80 in 2025. Among nephrology clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 167 payments — averaging $113.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$16K
- Mallinckrodt Hospital Products Inc.$666
- Fresenius USA Marketing, Inc.$349
- Otsuka America Pharmaceutical, Inc.$314
- OPKO Pharmaceuticals, LLC$260
- Amgen$218
- plus $1K from 14 others
What the payments were for
- Speaking & faculty fees$14,38176%
- Travel & lodging$6573%
- Food & beverage$3,30418%
- Education$5353%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 41 | $15,828 |
| Mallinckrodt Hospital Products Inc. | 21 | $666 |
| Fresenius USA Marketing, Inc. | 17 | $349 |
| Otsuka America Pharmaceutical, Inc. | 15 | $314 |
| OPKO Pharmaceuticals, LLC | 10 | $260 |
| Amgen(2 entities) | 9 | $218 |
| GSK | 12 | $212 |
| Travere Therapeutics, Inc. | 8 | $175 |
| AstraZeneca | 9 | $162 |
| Vifor Pharma, Inc. | 7 | $148 |
| Shionogi Inc | 2 | $145 |
| Novartis | 4 | $124 |
| Aurinia Pharma U.S., Inc. | 3 | $81 |
| Novo Nordisk | 1 | $50 |
| Calliditas Therapeutics US Inc. | 3 | $46 |
| Ardelyx, Inc. | 1 | $29 |
| Boehringer Ingelheim | 1 | $24 |
| Nxstage Medical, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,877 in reported general payments places this provider in the 90th percentile of 55 nephrology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Torsemide | 12 | $184 |
| Olmesartan Medoxomil | 13 | $80 |
| Amlodipine Besylate | 11 | $50 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Morgantown
- Rebecca SchmidtMorgantown$5K
- Adeem AkbarMorgantown$740
- Anas DiabMorgantown$482
- Anthony ParravaniMorgantown$166
- Bethany PellegrinoMorgantown$160
- Jennifer BergeronMorgantown$124
- Dinesh Kumar KannabhiranMorgantown$117
- Vijay VidyasagarMorgantown$40
- Sana AkbarMorgantown$34
- Mark PolingMorgantown$27
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.